Marex Group PLC (NASDAQ:MRX) is set to release its Q4 2024 earnings on Mar 6, 2025. The consensus estimate for Q4 2024 revenue is $378.44 million, and the earnings are expected to come in at $0.67 per ...

Marex Group PLC (MRX) reports a 40% increase in adjusted profit before tax and a 28% revenue growth, showcasing robust financial health and strategic expansion.

March 15, 2025 is the advance tax deadline for FY 2024-25. However, if you are a salaried individual and your employer ...

Marex Group PLC (MRX) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which ...

Crystal Palace forward Jean-Phillipe Mateta could emerge as a summer transfer target for Manchester United. United head coach ...

There is one area where India has always been at the forefront, and that is in missing the bus. We lost have opportunities at every paradigm shift that emerging technologies brought not because we ...

We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going to take a look at where Amneal Pharmaceuticals, Inc.

Jean-Philippe Mateta has scored 15 goals for Crystal Palace this season Crystal Palace forward Jean-Phillipe Mateta could emerge as a summer transfer target for Manchester United. United head ...

echo " 2) MRX-30 (arm-fslc-linux-gnueabi, MRX-30/15)" echo " 3) MRX-12 (arm-poky-linux-gnueabi, MRX-12)" echo " program -m 1 -s /home/work1005/opt/src -o test.exe ...

and MRX-15 for kidney cancer, which further strengthens the company's R&D layout in different therapeutic areas. Zhang Xinyuan, head of research at Kefangde Think Tank, said that for innovative ...

Barclays analyst Benjamin Budish maintained a Buy rating on Marex Group plc (MRX – Research Report) today and set a price target of $39.00. The company’s shares closed last Friday at $36.64.